Aim: To investigate cytomegalovirus, rubella, varicella, toxoplasma, and hepatitis B immune status and factors associated with susceptibility for infections among Pakistani pregnant women in Norway. Methods: A total of 206 pregnant Pakistani women living in Norway participated in the evaluation. Blood samples were collected during pregnancy and tested for IgG antibodies against cytomegalovirus, rubella virus, varicella-zoster virus, Toxoplasma gondii, and hepatitis B (HB) virus. Results: All women had IgG antibodies against cytomegalovirus. Positivity for rubella IgG was 92%, 93% had varicella IgG antibodies, while 17% had toxoplasma IgG. Eleven per cent were anti-HBc positive, one of whom was HBsAg positive, which means that blood and cervix secretions are infectious with risk of virus transmission to the baby at the time of birth. Six women were only anti-HBc positive, they may have low-level HB infection, and risk of transmission cannot be excluded. Age younger than 25 years, having less than two children, and having lived less than 5 years in Norway were factors significantly associated with varicella-seronegative status, and thus susceptible for primary infection. Conclusions: To decrease the incidence of neonatal and maternal morbidity related to rubella, varicella, toxoplasma, and hepatitis B in our Pakistani immigrant population, we should intensify our rubella antenatal screening programme and focus upon rubella vaccination postpartum. We should offer varicella-seronegative women immunisation, advise toxoplasma-seronegative women to avoid visit to their home country during pregnancy, and give hepatitis B vaccine to all newborns regardless of maternal HBsAg status.
Introduction
During the last 30-40 years Norway has experienced a considerable migratory influx from low-income countries. In 2009 these immigrants represented 7% of the total Norwegian population and around 26% of the population in the capital of Oslo [1] . Persons of Pakistani origin constitute the largest immigrant group, totalling 9% of the immigrant population. Labour migration to Norway from Pakistan started in the late 1960s. In 1975, immigration restriction for working purposes was imposed. Since then immigration to Norway from Pakistan has mainly been for the purposes of marriage or family reunion, and consanguineous marriages are common. Evidence exists that migration might give rise to several social and health problems [2] .
Infection status varies throughout the world. Usually the first generation of immigrants reflect their home country. A report from 2007 in Norway showed higher incidence of severe infectious diseases among immigrants from Africa and Asia compared with ethnic Norwegians, especially tuberculosis, human immunodeficiency virus (HIV), hepatitis A and B [3] .
Many of the common infections that can be transmitted from mother to child during pregnancy and childbirth can be prevented. Antenatal screening programmes can detect women at risk and offer Correspondence: Soen Eng Yap Bjerke, MD, Trivind Health Center, 3540 Nesbyen, Norway. E-mail: eng@online.no (Accepted 15 January 2011) treatment to mother and child in identified cases, or maternal vaccination programmes after birth to protect against infection in next pregnancy. Vaccination of newborns at risk is another option.
There are few studies reporting the infectious status of immigrants from low-income countries to Europe especially among pregnant women. A study from Italy reported higher incidence of neonatal mortality among infants born to immigrant mothers than newborns with Italian parents [4] . Maternal infections such as hepatitis B (HB), HIV, syphilis, and tuberculosis contributed to this finding. Adverse socioeconomic conditions such as maternal age less than 18 years, low familiar income, inadequate obstetric care, and difficulty in accessing the public health services were also more common among the immigrants [4] .
Cytomegalovirus (CMV) is the most common cause of viral intrauterine infection and may cause ear disorder in the infected infant. Treatment options are scarce and no vaccination exists [5] .
Vaccination in childhood against rubella, the most serious infection for pregnant women to acquire, has been well established in Western world for almost 40 years, while globally there are still many countries also in South East Asia that have not introduced the vaccine or just recently have started such a programme [6] . Rubella infection in early pregnancy is severe. Rubella syndrome consists of the classic triad of cataracts, deafness, and congenital heart disease [7] .
Chicken pox or varicella-zoster virus (VZV) infection may be serious and even fatal in pregnant women and newborn children. VZV is a childhood disease in Western world. The majority (95%) are infected before fertile age. Obstetric populations born in tropical or subtropical regions are likely to be seronegative for VZV. They will benefit from being tested for varicella immunity and offered vaccination outside pregnancy [8] . Preconceptional testing and vaccination is recommended to prevent maternal infection and is introduced by several physicians [9] .
Primary infection with parasite Toxoplasma gondii in pregnancy may be transmitted to the fetus, causing fetal infection and damage to the eye or brain. The outcome depends on gestational age at infection [10] . Screening programmes in pregnancy with repeated testing of seronegatives are offered in several European countries like France and Belgium. In the Nordic countries, hygienic and dietetic advice are recommended [11] . Studies from Norway and Sweden indicate that immigrants have higher prevalence of toxoplasma IgG antibodies than ethnic Scandinavians [12, 13] .
Hepatitis B is another infection that is a major health problem globally including Pakistan [14] . Mother to child transmission occurs most often through fetal exposure to blood or blood-contaminated fluids at or around birth. Up to 90% of the infected babies will become chronically infected [15] . Neonatal vaccination is introduced worldwide, mostly without screening of the mothers. In Norway, screening of pregnant women is offered to defined risk groups, including immigrants from countries where hepatitis B is common.
Little is known about the immune pattern of infectious disease in the immigrant population in the Nordic countries. It is assumed that immigrants from South East Asia are more susceptible of rubella and varicella infections, but have higher prevalence of hepatitis B carriership, CMV, and toxoplasma antibodies than ethnic Norwegians. To our knowledge, this is the first study about immune infectious status among Pakistani pregnant immigrants in Norway, in order to give public health recommendation for how to handle and prevent fetal and perinatal infection in this immigrant population.
Material and methods
The Pakistani women were randomly selected from the prenatal ultrasound screening in the two hospitals in Oslo (Rikshospitalet and Ullevål University Hospital). These two hospitals are the two maternity hospitals in Oslo where also the Pakistani women are offered prenatal ultrasound screening. No private clinics exists in Oslo, therefore we had to use these hospitals.
The first author came once a week over 2 years to Oslo for interviewing and blood collections of the Pakistani women who came to prenatal ultrasound screening at Rikshospitalet and Ullevål University Hospitals. Although we had asked the midwives and their assistants to register the Pakistani women the day the first author was there, it happened quite often that only 0-1 patient was registered, and the first author then went home to the immigrant women that had been at the hospitals that week. After 2 years, with this heavy workload with many home visits, we stopped the recruitment. A total of 206 women were interviewed, after giving their personal consents and signatures. All these women were living in Oslo or one of the suburbs, randomly selected and representative for that population. The blood samples, collected in EDTA tubes, were separated and plasma was frozen at -20 C.
In 2009 we analysed the IgG antibodies to CMV, rubella virus, VZV, T. gondii, and HB. If anti-HBc IgG was present, we analysed also for HBsAg and anti-HBs. Analysis of CMV IgG, rubella IgG, anti-HBc, HBsAg, and anti-HBs were performed with chemiluminescent immunoassay (CMIA) from Abbott Laboratories (Abbott Architect). Toxoplasma IgG analysis was performed with microparticle enzyme immunoassay from Abbott (Abbott Axsym). VZV IgG analysis used an enzyme immunoassay (Behring Enzygnost, Dade Behring).
IgG measurement were registered as ''negative'', ''grey zone'' which means neither negative nor positive, ''slightly positive'' which means that specificity may be uncertain, and ''positive''. In our study, we regard ''grey zone'' as ''negative'' and ''slightly positive'' as ''positive''.
The study was approved by the Regional Committee for Ethics and Research and the Data Inspectorate.
Variables
A structured questionnaire was used. Information about demographic and socioeconomic factors such as maternal age, marital status, parity, family income, and years of residence in Norway were registered.
Statistical analyses
All data were registered in SPSS. Descriptive statistics (including means, standard deviations, frequencies, and percentages) were analysed for distribution of the demographic variables. Crude adjusted odds ratios of being seropositivity for rubella, VZV, toxoplasma, and HB with 95% confidence intervals were estimated by logistic regression analyses for potential risk factors as maternal age, parity, family income, and years of residence in Norway.
Results
Population characteristics are presented in Table I . The average age of the participants was 27.3 years (range 18-44 years). Only five women were single. Thirty-two women (15.5%) had recently arrived in Norway (Table I) .
Serologic results
The seropositivity results for different infection according to age groups are shown in Figure 1 . All women had CMV IgG antibodies. Among 206 women who were tested for rubella IgG, 17 (8%) were negative. Six of these women were primiparous, four had one child before, and seven had more than one child. Five women had recently arrived, the remaining 12 women had lived 3-20 years in Norway.
Fourteen women (7%) were negative for VZV IgG antibodies. Six of these women were primiparous, seven had one child, and one woman had three children before. Five women had lived under 1 year in Norway and the remaining women 2-7 years. All women were tested for toxoplasma IgG. The majority (83%) were IgG negative. Table II shows serological status of HB. We found 183 (88.8%) were negative for anti-HBc IgG; the remaining 23 (11.2%) were anti-HBc positive, one of whom was HBsAg positive, while six women were anti-HBc positive, HBsAg, and anti-HBs negative, and 16 were anti-HBc and anti-HBs positive.
Factors associated with susceptibility of infection and ability for transmission
The factors associated with susceptibility of infection and ability for transmission of CMV, rubella, VZV, toxoplasma and HB are presented in Table III . Age younger than 25 years, having less than 2 children, and having lived less than 5 years in Norway were factors significantly associated with VZV-seronegative status and thus susceptible for primary infection. Being seropositive for rubella, toxoplasma, and hepatitis B infections were not significantly associated with any of the variables. All were CMV positive. Values are n (%).
Discussion
This study tries to enlighten the susceptibility to different infections in the Pakistani pregnant population in Norway. The first-generation Pakistani women came to Norway for marriages, most of them came from poor rural districts in Pakistan and they had low education. Our sample included these women representing the first-generation Pakistani immigrants. Their average age was lower and they had lower family income, more children, and more married women than ethnic Norwegian pregnant women. Potential biases in sampling and selection could arise from the authors being limited to oncea-week visits to Oslo, so the population probably does not include all potential women. According to Statistics Norway, the first-generation Pakistani women had lower education and income, compared to second-generation Pakistani women. The second generation is more similarly to the ethnic Norwegians. All Pakistani immigrant women had IgG antibodies against CMV compared to 70% of the Norwegian pregnant population [16] . Our results indicate that routine CMV antibody testing in pregnancy should not be included in the antenatal infectious panel [17] . CMV is a difficult disease to prevent. Handwashing is the golden hygienic measure. The advice from public health authorities is that seronegative pregnant women should not work in hospitals or homes for children with learning difficulties where some children supposedly may be CMV infected and excrete virus. Another problem is that reactivation may sometimes occur in seropositive women. Congenital CMV infection may be the most important cause of ear disorders [18] . Some countries thus recommend urine screening of newborns [19] .
In our study, only 8% of the Pakistani immigrants were rubella seronegative, and 2-5% of ethnic Norwegians [20] in contrast to 18% of pregnant women in Pakistan [21] . The global prevalence of rubella antibodies was significantly higher in indigenous women compared with immigrants [22] . In Australia, although the current rubella immunisation is effective and provides protection for most Australian-born women, immigrant women from countries where rubella vaccination is not widely practised have still very high susceptibility to rubella [23] . In Spain, rubella susceptibility of pregnant women from low-income countries is 10 times higher than that of Catalonian native women [24] . Among our 17 women that were rubella negative, 11 had more than one child. Only two of these women had delivered their children in Pakistan. We would expect that the remaining nine women were rubella IgG positive, since Norwegian maternity hospitals offers rubella vaccine to women with negative rubella IgG. It may be that rubella status was not checked in pregnancy, vaccine was not given to these women, or, more unlikely, these women were vaccine nonresponders. More focus should be put on rubella testing of our immigrants and vaccination of the negatives. We found only 14 (7%) women seronegative for VZV IgG. We expected higher proportion of VZV seronegatives since varicella is not too common in South EastAsia. Young age under 25 years old, having less than two children, and living less than 5 years in Norway were factors associated with susceptibility for VZV. It explains that women might be infected in Norway, through their children or surroundings. In Norway 90-95% of adults have been infected with VZV [20] . VZV infections occur worldwide, but spread less readily in countries with tropical climates than in those with temperate climates, resulting in higher rates of susceptibility to varicella in adults in tropical countries than in countries with cooler climates [25] . In countries with temperate climates, varicella is a disease of childhood; most cases occur in children before they are 10 years old, with 8-9% of children between the ages of 1 and 9 years developing the disease annually [26] . Physicians should therefore know the geographic origin of the patients and should consider testing varicella immunity in their obstetric patients born in tropical or subtropical regions [8] .
Vaccination should be offered postpartum to the women who are seronegative for VZV. Thirty-six (17%) women were toxoplasma IgG positive. The acquisition of T. gondii infection is through ingesting contaminated or infected food, water, or cat faeces. For seronegative women visits to their home country during pregnancy involve a considerable risk of toxoplasma infection. In Norway the seropositive rates among women in reproductive age are 10.0% [12] . It is previously reported that women with foreign names have a much higher prevalence than Norwegians (22.6%) [12] . In general, a higher prevalence has been found in ''warm countries'' compared to ''cold countries''. This difference may be explained by the influence of the climate on the survival of toxoplasma oocytes in the environment [10] . Thus seronegative immigrant women from a home country with high prevalence of toxoplasma should be advised to be tested in pregnancy, and if negative, they should postpone their visit to their home country to after the child is born [10] . If they travel in pregnancy they should be advised to be tested 3 weeks after the infectious exposure.
The prevalence of viraemic hepatitis B in Norway is low (less than 0.1%) [20] . In 2009, 95% of the newly detected chronic carriers were of foreign origins [20] . In our study only one woman (0.5%), who expected her fourth child, 31 years old, and had lived 10 years in Norway was HBsAg positive, which means that blood and cervix secretions are infectious with risk of virus transmission to the baby at the time of birth or shortly thereafter.
Six women between 20 and 34 years old, who had been resident in Norway between one and 12 years, might have low-level HB infection, and risk of transmission could not be excluded. One of these women expected her first child, three of them expected their second children, and the remaining two women expected their third and sixth child. Our results indicate that HB infection is more prevalent among pregnant Pakistani immigrants than in the native population in Norway, with risk of transmission to the newborn. Those over 35 years old seem to be or have been more infected with hepatitis B than the younger (data not shown).
In Greece, Albanian refugees reported that they were vaccinated with non-disposable needles and syringes and explained higher percentage of being infected by hepatitis virus. A probable important parenteral exposure globally is the use of non-disposable needles and syringes used in medical practice and vaccination programmes [27] . In the Nordic countries, however, all needles and syringes used in medical practice and vaccination programmes are disposables.
Since 1991 WHO (World Health Organization) recommended all member countries to introduce HB vaccine in their national vaccination programmes. With recent dramatic increases in HB vaccine production and decreases of the price, there are grounds for optimism that global HB infection rates may be reduced by as much as 90% over the next 10 years [28] . In Norway HB vaccination is not included in the mass vaccination since Norway is considered to have low prevalence of HB infection. In 2005 Norwegian Institute of Public Health estimated that we had 12,000-15,000 HB carriers (<0.1%). These are immigrants from high and middle endemic areas, plus injection addicts. The HB vaccine is today given to neonates where the parents originating from countries with high prevalence of hepatitis B, and specifically to newborns of mothers being HBsAg positive and those that are anti-HBc positive with negative HBsAg and anti-HBs [29] .
However, very recently a Norwegian working group suggests the inclusion of HB vaccination in a national programme [30] . Nevertheless, global travel is common, especially for the immigrants to visit their home countries. For the immigrant population, HB vaccine should be given to all newborns regardless of maternal HBsAg status.
Conclusion
Despite of the routine postpartum vaccination programme against rubella in Norwegian maternity wards, 8% of Pakistani women had no rubella IgG. We should hereafter intensify our antenatal rubella screening programme and focus upon vaccination of seronegatives after birth.
We found that 7% of the women were seronegative for VZV. We should consider testing varicella immunity of women in fertile age born in tropical and subtropical regions, and offer VZV vaccine to seronegative women before pregnancy. In that way neonatal and maternal morbidity and mortality related to VZV may be reduced.
We should recommend toxoplasma-seronegative women to avoid visits to their home countries during pregnancy to prevent congenital toxoplasma infection.
One should consider giving HB vaccine to all newborns regardless of maternal HBsAg status.
